December 13, 2013

 

 

 

For Immediate Release

 

Yvonne M. Psaila

Director of Marketing & Communications

Keystone Symposia on Molecular & Cellular Biology

+ 1 970-262-2676

yvonnep@keystonesymposia.org

 

 

Keystone Symposia Holds First Virtual Webcast; Live Event to Feature Experts on HIV/AIDS

 

SILVERTHORNE, CO – December 13, 2013 – Keystone Symposia is today holding its first-ever virtual webcast. The 90-minute, live event convenes at 1:00 PM EST on the topic of “HIV/AIDS: Strategies for an Endgame.” Free and open to all, the event will feature four panelists and a moderator discussing the optimal strategy to end the AIDS epidemic. The panelists will also incorporate questions submitted before and during the event from audience members, who will be joining from more than 80 countries worldwide.

 

Moderator Bruce Walker, M.D. of the Ragon Institute of MGH, MIT and Harvard will lead the discussion, which will also feature Myron (“Mike”) Cohen, M.D. of the University of North Carolina at Chapel Hill; Betsy Herold, M.D. of Albert Einstein College of Medicine; Julie McElrath, M.D., Ph.D. of Fred Hutchinson Cancer Research Center; and Gary Nabel, M.D., Ph.D. of Sanofi. A key focus will be whether it is most efficacious to devote resources to vaccines or PReP (pre-exposure prophylaxis).

 

The webcast is generously sponsored by Gilead Sciences, Inc.

 

Interested viewers can register to watch at www.visualwebcaster.com/KSHIV. Those who miss the live event will still be able to watch a taped version, which will be available at the same link approximately 72 hours later. In addition, the discussion will continue during a special workshop on the same topic at Keystone Symposia’s joint HIV vaccines and pathogenesis conferences, to be held March 9-14, 2014 in Banff, Alberta, Canada.

 

 

About Keystone Symposia on Molecular & Cellular Biology

Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been convening internationally renowned, open scientific conferences since its founding as UCLA Symposia in 1972 and has been headquartered in Colorado since 1990.

 

The organization will convene 58 conferences in the 2013-2014 season, the majority of which will take place between January and April 2014, on topics ranging from cancer and immunology to neuroscience and big data in biology. More information can be found at www.keystonesymposia.org and www.keystonesymposia.org/meetings. Further details on the March HIV conferences are available at www.keystonesymposia.org/14X3.